rs13207033 — TNFAIP3

Intergenic protective variant near TNFAIP3 that tags a haplotype associated with enhanced A20-mediated NF-kB suppression, reducing rheumatoid arthritis risk at the 6q23 locus

See your personal result for TNFAIP3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

TNFAIP3 6q23 — A Genetic Edge Against Autoimmune Disease

The 6q23 chromosomal region harbors one of the strongest known genetic influences on autoimmune disease risk. Most people know of this locus through its risk variants — but rs13207033 tells the other side of the story. This intergenic SNP, located near the TNFAIP3 gene on chromosome 6, tags a protective haplotype11 protective haplotype
A haplotype is a set of alleles inherited together on the same chromosome; rs13207033 marks a chromosomal block associated with higher TNFAIP3 activity that appears to enhance the activity of A20, the immune system's primary brake on NF-kB-driven inflammation. Carriers of the A allele show meaningfully reduced risk for rheumatoid arthritis.

TNFAIP3 encodes A20, a ubiquitin-editing enzyme22 ubiquitin-editing enzyme
A20 uses two functional domains: a deubiquitinase that removes activating ubiquitin chains and an E3 ligase that adds inhibitory chains, together terminating NF-kB signal transduction that terminates NF-kB inflammatory signaling after an immune response has served its purpose. Without sufficient A20 activity, inflammatory signals persist and self-reactive immune responses become more likely — the fundamental mechanism underlying most autoimmune diseases.

The Mechanism

rs13207033 is located in the intergenic region near TNFAIP3 on chromosome 6q23.3, in a ~60-kb stretch between the OLIG3 and TNFAIP3 genes that does not encode any transcripts. It does not alter any protein directly; instead, it tags a regulatory haplotype33 regulatory haplotype
A haplotype block in high linkage disequilibrium with rs13207033, meaning these alleles travel together across generations that appears to increase TNFAIP3 expression or enhance A20 function. The SNP is in perfect linkage disequilibrium44 linkage disequilibrium
LD means the alleles co-occur more frequently than chance would predict, so rs13207033 and rs10499194 are essentially interchangeable markers for the same protective haplotype (r² = 1) with rs10499194, the variant more frequently tested in Asian-population studies.

The Evidence

The protective nature of rs13207033 was established through conditional logistic regression55 conditional logistic regression
A statistical method that identifies whether a variant remains independently significant after accounting for the effects of other nearby variants fine-mapping of the 6q23 locus. After accounting for the known risk variants rs6920220 and rs5029937, rs13207033 remained independently associated with RA protection (OR 0.86, 95% CI 0.80–0.93, P=0.0001) in 3,962 RA patients and 3,531 controls from six UK centers.

A meta-analysis of six studies66 meta-analysis of six studies
Including 11,166 RA cases and 11,231 controls (11,166 cases / 11,231 controls) confirmed the protective association for GA vs GG genotype (OR 0.88, 95% CI 0.79–0.99, P=0.034) with the effect concentrated in Caucasian populations. No significant association was found in Asian populations, consistent with the lower A allele frequency in East Asian populations (~9.7% vs ~28% in Europeans).

The three-SNP model at 6q23 illustrates why individual variants tell only part of the story. The most dangerous haplotype combination — risk alleles at rs6920220 and rs5029937 with complete absence of the rs13207033 protective A allele — carries a combined OR of 1.8677 combined OR of 1.86
95% CI 1.51–2.29, from formal three-SNP conditional analysis in 3,962 RA cases for RA, compared to OR 0.86 for the protective A allele alone.

Practical Implications

Carrying one or two copies of the A allele at rs13207033 is genetically favorable — it indicates greater capacity for NF-kB self-regulation via A20. For most A-allele carriers, this is a reassuring counterweight against other inflammatory risk factors. For homozygous GG carriers (lacking the protective allele entirely), the loss of this inherent protective signal is clinically meaningful primarily in the context of the companion 6q23 risk variants; as an isolated finding, GG genotype represents the common baseline population risk.

Two large-scale RCT interventions directly target the NF-kB pathway that A20 regulates. The VITAL trial88 VITAL trial
A 5-year randomized controlled trial of 25,871 adults assigned to vitamin D3 2000 IU/day, omega-3 1 g/day, both, or placebo found vitamin D3 supplementation reduced incident autoimmune disease by 22% (HR 0.78, P=0.05) and omega-3 fatty acids reduced it by 15%. For GG carriers who lack the protective allele, these interventions represent the most evidence-backed approach to compensating for reduced genetic NF-kB braking capacity.

Interactions

rs13207033 is one of three statistically independent signals at the 6q23 locus. The other two — rs6920220 and rs5029937 (intronic in TNFAIP3, also risk) — are independently inherited and their combination with rs13207033 genotype substantially alters overall RA risk. Carrying both risk alleles for the other two SNPs while being GG at rs13207033 (i.e., lacking the protective A allele) yields OR 1.86, the highest risk configuration at this locus.

The TNFAIP3 missense variant rs2230926 (F127C) operates through a different mechanism — impaired A20 enzymatic activity rather than altered expression — and is independent of the 6q23 haplotype block. Carriers of both the rs2230926 G risk allele and rs13207033 GG genotype lack both the quantitative (expression-level) and qualitative (enzyme-activity) components of A20 function, a combination that warrants a dedicated compound action assessment.

Genotype Interpretations

What each possible genotype means for this variant.

GG Baseline A20 Regulation Normal

Common genotype lacking the 6q23 protective allele — baseline autoimmune risk

The three-SNP model at 6q23 is critical for interpreting rs13207033 GG. If you also carry the A risk allele at rs6920220 and/or the T risk allele at rs5029937 (intronic TNFAIP3 risk), the absence of the rs13207033 protective A allele removes the only counter-balancing genetic signal at this locus. The combined OR for RA under the worst-case three-SNP combination is 1.86 (95% CI 1.51–2.29) — substantially higher than any single 6q23 variant alone.

For GG carriers without risk alleles at the companion SNPs, this variant contributes little additional information beyond confirming absence of extra protection. The GG genotype does not impair A20 function — it simply reflects the population baseline without the bonus conferred by the A haplotype.

AA Enhanced A20 Protection Beneficial

Two copies of the protective A allele confer strong NF-kB self-regulation

You carry two copies of the protective A allele at this 6q23 regulatory region. Both chromosomes carry the haplotype associated with higher A20 expression, giving your immune cells robust NF-kB braking capacity. Studies show the A allele reduces rheumatoid arthritis risk (OR 0.86 per allele). Homozygous AA carriers represent approximately 8% of people of European descent.

AG Partial A20 Protection Intermediate

One protective A allele provides moderate NF-kB regulatory advantage

You carry one copy of the protective A allele at this 6q23 locus. Your cells likely express somewhat higher A20 levels than GG carriers, providing a partial advantage in terminating NF-kB inflammatory signals. The meta-analytic odds ratio for the A allele is 0.88 per copy for RA risk reduction. Approximately 40% of people of European descent share this heterozygous genotype. Your partial protective advantage does not eliminate autoimmune risk from other genetic or environmental factors.